• 제목/요약/키워드: SCLC

검색결과 131건 처리시간 0.036초

편평상피세포암종과 선암종이 동반된 복합형 소세포암종(Combined Small Cell Carcinoma) 1예 (A Case of Combined Small Cell Carcinoma with Non-Small Cell Lung Carcinoma, Adenocarcinoma and Squamous Cell Carcinoma)

  • 박혜정;문영철;유성근;신경철;정진홍;이관호;김미진;이정철
    • Tuberculosis and Respiratory Diseases
    • /
    • 제48권1호
    • /
    • pp.72-77
    • /
    • 2000
  • 저자들은 기침과 전신 쇄약감으로 내원하여 기관지내시경에 의한 조직생검에서 편평상피세포암종으로 진단되었으나 수술 후 소세포암종이 편평정상피세포암종과 선암종을 포함한 복합형 소세포암종 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

Prognostic Significance of Circulating Tumor Cells in Small-Cell Lung Cancer Patients: a Meta-analysis

  • Zhang, Jiao;Wang, Hai-Tao;Li, Bao-Guo
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권19호
    • /
    • pp.8429-8433
    • /
    • 2014
  • Circulating tumor cells (CTCs) are believed to be particularly important and a reliable marker of malignancy. However, the prognostic significance of CTCs detected in patients with small cell lung cancer (SCLC) is still unclear. We therefore aimed to assess the prognostic relevance of CTCs using a meta-analysis. We searched PubMed for relevant studies and statistical analyses were conducted to calculate the hazard ratio (HR) and 95% confidence intervals (CIs) using fixed or random-effect models according to the heterogeneity of included studies. A total of 7 papers covering 440 SCLC patients were combined in the final analysis. The meta-analysis revealed that CTCs were significantly associated with shorter overall survival (HR=1.9; 95%CI: 1.19-3.04; Z=2.67; P<0.0001) and progression-free survival (HR=2.6; 95%CI: 1.9-3.54; Z=6.04; P<0.0001). The results thus suggest that the presence of CTCs indicates a poor prognosis in patients with SCLC. Further well-designed prospective studies are required to explore the clinical applications of CTCs in SCLC.

Effect of silica fume and polyepoxide-based polymer on electrical resistivity, mechanical properties, and ultrasonic response of SCLC

  • Mazloom, Moosa;Allahabadi, Ali;Karamloo, Mohammad
    • Advances in concrete construction
    • /
    • 제5권6호
    • /
    • pp.587-611
    • /
    • 2017
  • This study focused on the influences regarding the use of polyepoxide-based polymer and silica fume (SF) on the fresh and hardened state properties of self-compacting lightweight concrete (SCLC) along with their impacts on electrical resistance and ultrasonic pulse velocity (UPV). To do so, two series of compositions each of which consists of twelve mixes, with water to binder (W/B) ratios of 0.35 and 0.4 were cast. Three different silica fume/binder ratios of 0, 5%, and 10% were considered along with four different polymer/binder ratios of 0, 5%, 10%, and 15%. Afterwards, the rupture modulus, tensile strength, 14-day, 28-day, and 90-day compressive strength, the UPV and the electrical resistance of the mixes were tested. The results indicated that although the use of polymer could enhance the passing and filling abilities, it could lead to a decrease of segregation resistance. In addition, the interaction of the SF and the polymeric contents enhanced the workability. However, the impacts regarding the use of polymeric contents on fresh state properties of SCLC were more prevalent than those regarding the use of SF. Besides the fresh state properties, the durability and mechanical properties of the mixes were affected due to the use of polymeric and SF contents. In other words, the use of the SF and the polymer enhanced the durability and mechanical properties of SCLC specimens.

신경계 증상을 동반한 부분적으로 자연완화된 소세포폐암 (Partial spontaneous remission of small cell lung carcinoma with neurologic symptom)

  • 윤경현;송성헌;김충현;황찬희;이준호;최재형;김선영
    • Journal of Yeungnam Medical Science
    • /
    • 제34권2호
    • /
    • pp.275-278
    • /
    • 2017
  • Small cell lung carcinoma (SCLC) is a cancer that shows aggressive behavior, early spread to distant sites, and frequent association with distinct paraneoplastic syndromes. Spontaneous remission of cancer, particularly of SCLC, is a rare biological event. Cases involving spontaneous regression of SCLC were reported, and were associated with paraneoplastic syndromes of the nervous system. This article reports on a 78-year-old man with SCLC in remission, with neurological symptoms. The patient visited the hospital because of generalized weakness, and imaging studies revealed a mass in the lower lobe of the left lung, pathological evaluation showed SCLC. The patient refused oncologic treatment and was treated only with conservative care. In follow-up study the diameter of the mass had decreased from initial 32 mm, 9 months after admission to 20 mm, 17 months after admission to 13 mm. The patient kept complaining of generalized weakness, dizziness, and paresthesia of limbs. We assumed that, in this case, the spontaneous remission of lung cancer was related to the immunologic response directed against the tumor, which is believed to be an important factor in the pathogenesis of paraneoplastic neurologic syndromes.

Clinical Outcomes after Upfront Surgery in Clinical Stage I-IIA Small Cell Lung Cancer

  • Hyeok Sang, Woo;Jae Won, Song;Samina, Park;In Kyu, Park;Chang Hyun, Kang;Young Tae, Kim
    • Journal of Chest Surgery
    • /
    • 제55권6호
    • /
    • pp.470-477
    • /
    • 2022
  • Background: Upfront surgery followed by systemic treatment is recommended to treat clinical stage I-IIA small cell lung cancer (SCLC), but data on the clinical outcomes are sparse. Thus, this study evaluated the stage migration and long-term prognosis of surgically treated clinical stage I-IIA SCLC. Methods: We retrospectively reviewed 49 patients with clinical stage I-IIA SCLC who underwent upfront surgery between 2000 and 2020. Additionally, we re-evaluated the TNM (tumor-node-metastasis) staging according to the eighth edition of the American Joint Committee on Cancer staging system for lung cancer. Results: The clinical stages of SCLC were cIA in 75.5%, cIB in 18.4%, and cIIA in 6.1% of patients. A preoperative histologic diagnosis was made in 65.3% of patients. Lobectomy and systematic lymph node dissection were performed in 77.6% and 83.7% of patients, respectively. The pathological stages were pI in 67.3%, pII in 24.5%, pIII in 4.1%, and pIV in 4.1% of patients. The concordance rate between clinical and pathological stages was 44.9%, and the upstaging rate was 49.0%. The 5-year overall survival (OS) rate was 67.8%. No significant difference in OS was found between stages pI and pII. However, the OS for stages pIII/IV was significantly worse than for stages pI/II (p<0.001). Conclusion: In clinical stage I-IIA SCLC, approximately half of the patients were pathologically upstaged, and OS was favorable after upfront surgery, particularly in pI/II patients. The poor prognosis of pIII/IV patients indicates the necessity of intensive preoperative pathologic mediastinal staging.

나노 복합체를 이용한 유기 메모리 소자의 전기적 동작 특성 분석

  • 안성우;김태환
    • 한국진공학회:학술대회논문집
    • /
    • 한국진공학회 2016년도 제50회 동계 정기학술대회 초록집
    • /
    • pp.327.2-327.2
    • /
    • 2016
  • 유기물/무기물 나노 복합체를 이용한 전자 소자는 간단한 공정과 고집적 및 플렉시블 응용 가능성으로 차세대 전자 소자로서 응용 연구가 많이 시도되고 있다. 무기물의 경우 전하 전송 메커니즘과 전기적 특성에 영향을 미치는 다양한 요인들에 대한 연구가 많이 진행되었지만 유기물의 경우 소자의 특성에 집적적으로 영향을 미치는 요인들에 대한 이론적 연구가 미흡하다. 본 연구에서는 금속/유기물 경계면의 전하전송, 트랩밀도 및 전하 이동도가 소자의 전기적 특성에 어떠한 영향을 미치는지 분석하였다. 유기 메모리 소자의 전하 전송 메커니즘을 분석하기 위해 PMMA에 나노 입자를 분산시킨 유기-나노 복합층을 사용하여 유기 메모리 소자를 제작하였고 SCLC 이론을 이용하여 전기적 특성을 분석하였다. 또한 전극과 유기-나노 복합층 사이에 C60 층을 삽입하여 트랩밀도와 전하이동도가 유기물 전자 소자에 어떻게 영향을 미치는지에 대한 이론적인 연구를 하였다. SCLC 이론을 이용하여 계산한 current density -voltage (J-V) 특성 이론값과 실험값의 비교 분석으로 유기물전자 소자의 전기적 동작 특성에 대한 메커니즘을 규명하였으며, 유기물 메모리 소자에서 트랩밀도와 분포가 전기적 특성에 미치는 영향에 대하여 연구하였다.

  • PDF

소세포폐암의 수술 성적 (Surgical Resection of Small Cell Lung Cancer(SCLC))

  • 정경영;홍기표;김길동;김대준;김주항
    • Journal of Chest Surgery
    • /
    • 제31권12호
    • /
    • pp.1195-1199
    • /
    • 1998
  • 배경: 소세포폐암에 있어 수술의 적응은 제한적이었으며 수술의 결과에 대하여서도 논란이 많다. 대상 환자는 1992년 1월부터 1996년 12월까지 신촌세브란스 흉부외과에서 수술한 9명의 환자로서 남자가 8명, 여자가 1명이었으며 평균 연령은 57.2세(range; 35∼76세)이었다. 대상 및 방법: 수술전 소세포폐암으로 진단되었던 예는 5예이었으며 4예에서의 수술전 진단은 분화가 안된 편평상피세포암이었다. 수술은 전예에서 폐절제술 및 종격동림프절박리술을 시행하였고 폐단엽절제술이 5예, 폐단엽절제술과 분엽절제술 및 늑골을 포함한 En-block 절제 1예, 폐이엽절제술 2예, 전폐절제술 1예 등이었다. 결과: 수술사망 예는 없었으며 수술 후 합병증으로는 출혈 1예, 심부정맥 1예 등이 있었다. 수술 후 전예에서 소세포암이 확인되었고 수술 후 병기는 T1N0M0 1예, T2N0M0 4예, T3N0M0 1예, T3N1M0 1예, T2N2M0 1예, T4N0M0 1예이었다. 수술 후 5예에서는 항암화학요법을, 4예에서는 항암화학요법 및 방사선치료를 시행하였다. 전예에서 추적이 가능하여 평균 추적기간은 평균 33.0개월(1-63개월이었고 추적기간중 림프절로의 전이가 없는 경우 6예 중에서는 1예에서만 장골에 전이가 발견되었으나 생존해있고, 림프절로의 전이가 있거나 T4 병변인 3예에서는 2예는 국소 부위, 1예는 뇌에 재발이 있었으며 이중 2예는 사망하였다. 결론: 소세포폐암에서도 TNM 병기가 유용하며 종격동 또는 구역 림프절로의 전이가 없는 경우에는 수술 후 성적이 양호하여 초기 병기의 소세포폐암 환자에서는 항암화학요법과 함께 적극적인 수술 절제가 필요한 것으로 생각된다.

  • PDF

제한병기 소세포폐암에서 흉부 방사선 치료의 도입 시기에 따른 치료 효과의 비교 분석 (The effects according to the timing of thoracic radiotherapy in limited stage small cell lung cancer)

  • 박상기;김근화;정성수;신경상;김애경;조해정;서지원;김재성;조문준;김주옥;김선영
    • Tuberculosis and Respiratory Diseases
    • /
    • 제43권6호
    • /
    • pp.903-915
    • /
    • 1996
  • Background: Combination chemotherapy is now considered to be the cornerstone of small cell lung cancer (SCLC). management but the optimal management of limited SCLC is not well defined. The role of thoracic radiotherapy (TRT) is less well established. Recent meta-analyses reports revealed that TRT combined with chemotherapy produce "good" local control and prolonged survival. But other reports that survival was not changed. The liming, dose, volume and fractionation for TRT with the combined chemotherapy of SCLC remains unsettled. In this study, we analyzed the effects according to the timing of thoracic radiotherapy in limited SCLC. Method: All fifty one patients received cytoxan, adriamycin and vincristine(CAV) alternating with etoposide and cisplatin(VPP) every 3 weeks for 6 cycles were randomized prospectively into two groups: concurrent and sequential. 27 patients received 4500cGy in 30 fractions(twice daily 150cGy fractional dose) over 3 weeks 10 the primary site concurrent with the first cycle of VPP(concurrent gorup). 24 patients received 4000 to 5000cGy over 5 or 6 weeks after completion of sixth cycles of chemotherapy(sequential group). Results: 1. Response rates and response duration : Response rates were not significantly different between two groups(p=0.13). But response duration was superior in the concurrent group(p=0.03). 2. Survival duration was nor different between two groups(p=0.33). 3. Local control rate was superior in the concurrent group(p=0.00). 4. Side effects and toxicities: Hematologic toxicities, especially leukopenia, infection and frequency of radiation esophagitis were higher in the concurrent group (p=0.00, 0.03, 0.03). Conclusion: The concurrent use of TRT with chemotherapy failed to improve the survival of limited stage SCLC patients compared with the sequential use of TRT but response duration and local control rate were superior in the concurrent group. Frequency of radiation esophagitis, life threatening hematologic toxicities and infection were more frequent in the concurrent group than sequential group. So, the selection of an optimal schedule of chemotherapy combined with TRT that would lead to a major increase in survival with minimal toxicity is remained to be validated in large scale study in the future.

  • PDF

기관지표면상피의 미세침윤성 편평세포암과 동반된 혼합성 소세포암종 -1례 보고- (Combined Small Cell Carcinoma Associated with Microinvasive Squamous Cell Carcinoma of Bronchial Surface Epithelium - A case report -)

  • 김윤정;심정원
    • Journal of Chest Surgery
    • /
    • 제29권9호
    • /
    • pp.1031-1035
    • /
    • 1996
  • 폐의 편평상피암종에서 기관지표면상피의 화생에 대해서는 많은 이들에 의해서 밝혀진 바 있지만 그 외의 다른 종류의 폐암과 연관된 기관지 표면상피의 변화에 대해서는 그 예가 많지 않고 소세포폐암종에 대해서는 더욱 그러하다. 한편 소세포암종의 조직학적 분류와그아형에 대해서 지난수십년 간많은 관심이 모아져 왔다. 이 종량의 아형을분류하는기본적인 근거는 그 형태학적 판정 기준에 있다. 1967년 WHO폐암종 분류법이 제긍된 이후 3여러 기관에서 SCLC의 임상경과나 치료에 대한 반응, 그 아형을 연구하였다. 1988년 IASLC에서는 소세포암종을 그 형태학적 구분으로 세가지 아형 : Small cell carcinoma (2) Mixed small cel1/1arge ceil carcinoma (3) Combined small cell carcinoma로 분류하고 예후와 치료에 대한 반응의 차이에 대해서 언급하였다. 최근 저자들은 68세 남자환자에서 소세포암종에서 국소적으로 편평양분화를 보이는 세포가 함께 혼합되어 있는 주종괴와 분리되 어서 존재하는 기관지 상피세포에 편평상피암종이 동반된 예를 전폐 절제 술을 하고 조직 검사상 경험하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

Comparison of Vinorelbine, Ifosfamide and Cisplatin (NIP) and Etoposide and Cisplatin (EP) for Treatment of Advanced Combined Small Cell Lung Cancer (cSCLC) Patients: A Retrospective Study

  • Luo, Jie;Wu, Feng-Ying;Li, Ai-Wu;Zheng, Di;Liu, Jin-Ming
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권9호
    • /
    • pp.4703-4706
    • /
    • 2012
  • Objective: To compare efficacy and safety profile of vinorelbine, ifosfamide and cisplatin (NIP) with etoposide and cisplatin (EP) in the treatment of advanced combined small cell lung cancer (c-SCLC). Methods: From January 2006 to December 2010, 176 patients with advanced c-SCLC were enrolled. The primary endpoint was overall survival (OS) and the secondary endpoints were progression free survival (PFS), response rate (RR) and toxicity. Results: Overall RR was 30.0% in the NIP and 38.5% in the EP group; there was no significant difference (P=0.236). The PFS in the EP group was little longer than that of NIP group, with 6.5 months for EP and 6.0 months for NIP group, but the difference was statistically non-significant (P=0.163). The median OS and one year survival rates were 10.4 months and 36.3% for NIP group, and 10.8 months and 49.0% for EP respectively, EP showing a survival benefit, although this was not statistically significant. Both groups well tolerated the adverse effects. The incidence of grade I-II leucopenia and alopecia in the NIP group was significantly higher than that of EP group (32.5% vs. 10.4% (P<0.001, 35.0% vs. 12.5%, P<0.001). Conclusion: the ORR, PFS and OS in NIP were slightly inferior to traditional regimen EP. The toxicity of NIP can be considered tolerable. The usage of three drugs combination in the treatment of mixed SCLC remains uncertain. Nevertheless, the results need to be further confirmed by large, prospective clinical trials.